Wanchaijiraboon, P.; Sainamthip, P.; Teeyapun, N.; Luangdilok, S.; Poovorawan, Y.; Wanlapakorn, N.; Tanasanvimon, S.; Sriuranpong, V.; Susiriwatananont, T.; Zungsontiporn, N.;
et al. Safety Following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVac. Vaccines 2023, 11, 356.
https://doi.org/10.3390/vaccines11020356
AMA Style
Wanchaijiraboon P, Sainamthip P, Teeyapun N, Luangdilok S, Poovorawan Y, Wanlapakorn N, Tanasanvimon S, Sriuranpong V, Susiriwatananont T, Zungsontiporn N,
et al. Safety Following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVac. Vaccines. 2023; 11(2):356.
https://doi.org/10.3390/vaccines11020356
Chicago/Turabian Style
Wanchaijiraboon, Passakorn, Panot Sainamthip, Nattaya Teeyapun, Sutima Luangdilok, Yong Poovorawan, Nasamon Wanlapakorn, Suebpong Tanasanvimon, Virote Sriuranpong, Thiti Susiriwatananont, Nicha Zungsontiporn,
and et al. 2023. "Safety Following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVac" Vaccines 11, no. 2: 356.
https://doi.org/10.3390/vaccines11020356
APA Style
Wanchaijiraboon, P., Sainamthip, P., Teeyapun, N., Luangdilok, S., Poovorawan, Y., Wanlapakorn, N., Tanasanvimon, S., Sriuranpong, V., Susiriwatananont, T., Zungsontiporn, N., & Pakvisal, N.
(2023). Safety Following COVID-19 Booster Vaccine with BNT162b2 Compared to mRNA-1273 in Solid Cancer Patients Previously Vaccinated with ChAdOx1 or CoronaVac. Vaccines, 11(2), 356.
https://doi.org/10.3390/vaccines11020356